DISPROCYNIUM24, A NOVEL INHIBITOR OF THE EXTRANEURONAL MONOAMINE TRANSPORTER, HAS POTENT EFFECTS ON THE INACTIVATION OF CIRCULATING NORADRENALINE AND ADRENALINE IN CONSCIOUS RAT
G. Eisenhofer et al., DISPROCYNIUM24, A NOVEL INHIBITOR OF THE EXTRANEURONAL MONOAMINE TRANSPORTER, HAS POTENT EFFECTS ON THE INACTIVATION OF CIRCULATING NORADRENALINE AND ADRENALINE IN CONSCIOUS RAT, Naunyn-Schmiedeberg's archives of pharmacology, 354(3), 1996, pp. 287-294
The role of extraneuronal uptake in terminating the actions of catecho
lamines has been difficult to evaluate in vivo, largely because of lac
k of suitable inhibitors. The compound, 1,1'-diisopropyl-2,4'-cyanine
iodide or disprocynium24 (D24), is a novel inhibitor of extraneuronal
uptake with a high degree of potency in vitro. This study examined the
actions of D24 on the inactivation and metabolism of circulating nora
drenaline and adrenaline in conscious rats. Animals received i.v. infu
sions of H-3-labelled noradrenaline and adrenaline, and their extraneu
ronal O-methylated metabolites, normetanephrine and metanephrine. Plas
ma concentrations of endogeneous and H-3-labelled catecholamines and m
etanephrines were measured before and after D24. D24 caused large incr
eases in plasma concentrations of noradrenaline and adrenaline, effect
s due to both decreases in their plasma clearances and increases in th
eir rates of release into plasma, Plasma concentrations of normetaneph
rine and metanephrine also increased due to their decreased clearance
from plasma. Increased release of normetanephrine into plasma did not
contribute to increased plasma concentrations of normetanephrine. In f
act, the contribution of extraneuronal O-methylation to noradrenaline
clearance decreased substantially after D24. The data indicate that D2
4 is a potent inhibitor of the extraneuronal catecholamine transporter
in vivo and that this process contributes importantly to the removal
of circulating catecholamines and their O-methylated amine metabolites
. Increased release of noradrenaline into plasma may reflect an increa
se in the proportion of transmitter that escapes from sites of release
into the circulation. However, increased adrenaline release indicates
that the drug also causes sympathoadrenal. activation.